Clinical Study
Intranasal Dexmedetomidine on Stress Hormones, Inflammatory Markers, and Postoperative Analgesia after Functional Endoscopic Sinus Surgery
Table 1
Subject and procedure characteristics.
| | Characteristic | Treatment groups | | Placebo group () | DEX group () | value |
| | Age (years) | 37.4 (12.5) | 37.2 (12.3) | 0.951 | | Gender (M/F) | 17/13 | 14/16 | 0.747 | | Weight (kg) | 67.1 (8.3) | 64.7 (9.6) | 0.305 | | Height (cm) | 163.5 (8.3) | 163.1 (7.9) | 0.867 | | Procedures | | | | | Septoplasty () | 12 (40%) | 9 (30%) | NS | | Functional endoscopic sinus surgery () | 12 (40%) | 15 (50%) | NS | | Septoplasty + functional endoscopic sinus surgery () | 6 (20%) | 6 (20%) | NS | | Duration of surgery (min) | 79.6 (23.9) | 83.6 (19.8) | 0.487 | | Blood loss (mL) | 78.2 (33.8) | 60.0 (29.2) | 0.030 |
|
|
Values are given as Mean SD, or number of patients (%).
|
